One of the primary benefits of CTLA-4 inhibitors is their ability to provide durable responses in some patients, leading to long-term remission. Unlike traditional chemotherapy, which targets rapidly dividing cells and can affect both cancerous and healthy cells, CTLA-4 inhibitors specifically enhance the body's immune response against cancer cells. This targeted approach can lead to fewer side effects and improved quality of life for patients.
